Full Text View
Tabular View
No Study Results Posted
Related Studies
Furosemide in Early Acute Kidney Injury (SPARK)
This study is currently recruiting participants.
Study NCT00978354   Information provided by University of Alberta
First Received: September 14, 2009   Last Updated: December 18, 2011   History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
No publications provided by University of Alberta

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Bagshaw SM, Gibney RT, McAlister FA, Bellomo R. The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury. Trials. 2010 May 11;11:50.




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services